Related Experiment Video
Updated: Mar 6, 2026

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
Published on: February 28, 2021
11C-PBR28 and 18F-PBR111 Detect White Matter Inflammatory Heterogeneity in Multiple Sclerosis
Gourab Datta1, Alessandro Colasanti1,2, Nicola Kalk1
1Division of Brain Sciences, Department of Medicine, Imperial College London, London, United Kingdom.
Abstract:
The objective of this study was to assess microglial activation in lesions and in normal-appearing white matter (NAWM) of multiple sclerosis (MS) patients using PET. Methods: Thirty-four MS patients (7 with secondary progressive MS [SPMS], 27 with relapsing remitting MS [RRMS]) and 30 healthy volunteers, genetically stratified for translocator protein (TSPO) binding status, underwent PET scanning with TSPO radioligands (11C-PBR28 or 18F-PBR111). Regional TSPO availability was measured as a distribution volume ratio (DVR) relative to the caudate (a pseudoreference region). White matter lesions (WMLs) were classified as "active" (DVR highest in the lesion), "peripherally active" (perilesional DVR highest), "inactive" (DVR highest in surrounding NAWM), or "undifferentiated" (similar DVR across lesion, perilesional and NAWM volumes). Results: The mean DVR in NAWM of patients was greater than that of the healthy volunteer white matter for both radioligands. Uptake for individual WML in patients was heterogeneous, but the median WML DVR and NAWM DVR for individual patients were strongly correlated (ρ = 0.94, P = 4 × 10-11). A higher proportion of lesions were inactive in patients with SPMS (35%) than RRMS (23%), but active lesions were found in all patients, including those on highly efficacious treatments. Conclusion: TSPO radioligand uptake was increased in the brains of MS patients relative to healthy controls with 2 TSPO radiotracers. WML showed heterogeneous patterns of uptake. Active lesions were found in patients with both RRMS and SPMS. Their independent prognostic significance needs further investigation.
Insights
Positron emission tomography (PET) scans revealed increased translocator protein (TSPO) binding in multiple sclerosis (MS) patients compared to controls. Active lesions were present in both relapsing remitting MS (RRMS) and secondary progressive MS (SPMS) patients.
Area of Science:
- Neuroscience
- Radiology
- Immunology
Background:
- Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system.
- Microglial activation is a key pathological feature in MS, contributing to neuroinflammation and neurodegeneration.
- Translocator protein (TSPO) is a marker of neuroinflammation, often upregulated in activated microglia.
Purpose of the Study:
- To assess microglial activation in lesions and normal-appearing white matter (NAWM) in MS patients using Positron Emission Tomography (PET).
- To investigate the relationship between TSPO availability and different lesion types in MS.
- To compare TSPO binding in MS patients with healthy volunteers.
Main Methods:
- Thirty-four MS patients (7 SPMS, 27 RRMS) and 30 healthy volunteers underwent PET scanning.
- TSPO radioligands (11C-PBR28 or 18F-PBR111) were used to measure regional TSPO availability (distribution volume ratio, DVR).
- White matter lesions (WMLs) were classified based on DVR patterns: active, peripherally active, inactive, or undifferentiated.
Main Results:
- Mean TSPO DVR in NAWM was significantly higher in MS patients than in healthy controls for both radioligands.
- WMLs exhibited heterogeneous TSPO uptake patterns, but individual WML DVR strongly correlated with individual patient NAWM DVR.
- Active lesions were detected in all MS patients, including those on advanced treatments, with a higher proportion of inactive lesions in SPMS compared to RRMS.
Conclusions:
- TSPO radioligand uptake is elevated in the brains of MS patients, indicating increased neuroinflammation.
- WMLs in MS display diverse patterns of TSPO binding, suggesting varied inflammatory states.
- The presence of active lesions across all MS subtypes warrants further investigation into their prognostic significance.
![PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F57243.jpg&w=3840&q=50)
